EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The complex role of MEG3: An emerging long non-coding RNA in breast cancer

Md Sadique Hussain, Abdullah A Majami, Haider Ali, Gaurav Gupta, Waleed Hassan Almalki, Sami I Alzarea, Imran Kazmi, Rahamat Unissa Syed, Nasrin E Khalifa, Mohammed Khaled Bin Break, Ruqaiyah Khan, Najla Altwaijry und 1 weitere

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154850 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Md Sadique Hussain und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, Rajasthan, India. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: University of Ha'il.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MEG3, a significant long non-coding RNA (lncRNA), substantially functions in diverse biological processes, particularly breast cancer (BC) development. Within the imprinting DLK-MEG3 region on human chromosomal region 14q32.3, MEG3 spans 35 kb and encompasses ten exons. It exerts regulatory effects through intricate interactions with miRNAs, proteins, and epigenetic modifications. MEG3's multifaceted function in BC is evident in gene expression modulation, osteogenic tissue differentiation, and involvement in bone-related conditions. Its role as a tumor suppressor is highlighted by its influence on miR-182 and miRNA-29 expression in BC. Additionally, MEG3 is implicated in acute myocardial infarction and endothelial cell function, emphasising cell-specific regulatory mechanisms. MEG3's impact on gene activity encompasses transcriptional and post-translational adjustments, including DNA methylation, histone modifications, and interactions with transcription factors. MEG3 dysregulation is linked to unfavourable outcomes and drug resistance. Notably, higher MEG3 expression is associated with enhanced survival in BC patients. Overcoming challenges such as unravelling context-specific interactions, understanding epigenetic control, and translating findings into clinical applications is imperative. Prospective endeavours involve elucidating underlying mechanisms, exploring epigenetic alterations, and advancing MEG3-based diagnostic and therapeutic approaches. A comprehensive investigation into broader signaling networks and rigorous clinical trials are pivotal. Rigorous validation through functional and molecular analyses will shed light on MEG3's intricate contribution to BC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsRNA, Long NoncodingFemaleHumansCell ProliferationDNA MethylationGene Expression Regulation, NeoplasticProspective Studies

Stichwörter der Autor:innen

Breast cancerLong non-coding RNAMEG3miRNAs

Substanzen

MicroRNAsRNA, Long NoncodingMEG3 non-coding RNA, human

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, 302017, Jaipur, Rajasthan, India.
  • Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pharmacology, Kyrgyz State Medical College, Bishkek, Kyrgyzstan. Electronic address: haiderali.pharma@hotmail.com.
  • Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India; Sch…
  • Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.

Förderung

  • University of Ha'il

Zitieren

APA

Hussain, M. S., Majami, A. A., Ali, H., Gupta, G., Almalki, W. H., Alzarea, S. I., Kazmi, I., Syed, R. U., Khalifa, N. E., Bin Break, M. K., Khan, R., Altwaijry, N., & Sharma, R. (2023). The complex role of MEG3: An emerging long non-coding RNA in breast cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154850

Vancouver

Hussain MS, Majami AA, Ali H, Gupta G, Almalki WH, Alzarea SI, et al. The complex role of MEG3: An emerging long non-coding RNA in breast cancer. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154850

BibTeX
@article{Hussain2023,
  author = {Hussain, Md Sadique and Majami, Abdullah A and Ali, Haider and Gupta, Gaurav and Almalki, Waleed Hassan and Alzarea, Sami I and Kazmi, Imran and Syed, Rahamat Unissa and Khalifa, Nasrin E and Bin Break, Mohammed Khaled and Khan, Ruqaiyah and Altwaijry, Najla and Sharma, Rahul},
  title = {The complex role of MEG3: An emerging long non-coding RNA in breast cancer},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154850}
}
Kostenlos starten →